CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 131 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $83,000 | -68.3% | 13,175 | -61.1% | 0.00% | -100.0% |
Q1 2021 | $262,000 | -55.8% | 33,845 | -62.6% | 0.00% | 0.0% |
Q4 2020 | $593,000 | -1.5% | 90,602 | 0.0% | 0.00% | -50.0% |
Q3 2020 | $602,000 | +46.1% | 90,602 | +82.9% | 0.00% | +100.0% |
Q2 2020 | $412,000 | +8.4% | 49,524 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $380,000 | – | 49,524 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |